Despite the possibility of already reduced DAT levels, further blocking the DAT improved cognitive deficits, as recently observed in animal models of aging and AD (Xu et al., 2021; Yin et al., 2023). The gene discussed is SLC6A3; the disease is Alzheimer disease.